Skip to main content
. 2019 Aug 13;21(11):2429–2439. doi: 10.1111/dom.13824

Figure 1.

Figure 1

A, Least squares mean (LSM) change in body weight from baseline over the 20‐wk treatment period, B, Overall reduction at week 21 and C, Percentage of participants who lost at least 5% and 10% body weight at week 21 (full analysis set). Week 1 indicates baseline. Arrows indicate weeks of injection, which occurred at the beginning of the week. **P < 0.01 vs. placebo; ***P < 0.0001 vs. placebo. Abbreviations: Q2W, once every 2 wk; QW, once weekly